Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment

被引:159
作者
Ohno-Matsui, K
Hirose, A
Yamamoto, S
Saikia, J
Okamoto, N
Gehlbach, P
Duh, EJ
Hackett, S
Chang, M
Bok, D
Zack, DJ
Campochiaro, PA
机构
[1] Johns Hopkins Univ, Sch Med, Dept Ophthalmol & Neurosci, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21287 USA
[3] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90024 USA
[5] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/S0002-9440(10)64891-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Transgenic. mice with vascular endothelial growth factor (VEGF) driven by the rhodopsin promoter (rho/VEGF mice) develop neovascularization that originates from the deep capillary bed of the retina and grows into the subretinal space. in rho/VEGF mice, VEGF expression in photoreceptors begins between postnatal days 5 and 7, the period when the deep capillary bed is developing. An important question is whether or not the developmental stage of the deep capillary bed is critical for occurrence of neovascularization. Also, although rho/VEGF mice are extremely useful for the study of ocular neovascularization, there are some applications for which the early onset of VEGF expression is a disadvantage. In this study, we used the reverse tetracycline transactivator (rtTA) inducible promoter system coupled to either the rhodopsin or interphotoreceptor retinoid-binding protein (IRBP) promoter to control the time of onset of VEGF transgene expression in photoreceptors. in the absence of doxycycline, adult double-transgenic rho/rtTA-TRE/VEGF or IRBP/rtTA-TRE/VEGF mice showed little VEGF transgene expression and no phenotype. The addition of doxycycline to the drinking water resulted in prominent transgene expression and evidence of neovascularization within 3 to 4 days. Like rho/VEGE mice, the neovascularization originated from the deep capillary bed of the retina, but it was more extensive and caused outer retinal folds followed by total retinal detachment. Real-time polymerase chain reaction and enzyme-linked immunosorbent assay demonstrated that the mice with inducible expression of VEGF that developed retinal detachment had much higher ocular levels of VEGF mRNA and protein compared to rho/VEGF mice that manifest a much milder phenotype. These data demonstrate that regardless of developmental stage of the vascular bed, increased expression of VEGF in the retina is sufficient to cause neovascularization, and high levels of expression cause severe neovascularization and traction retinal detachment. Mice with inducible expression of VEGF in the retina provide a valuable new model of ocular neovascularization.
引用
收藏
页码:711 / 719
页数:9
相关论文
共 26 条
  • [11] MILLER JW, 1994, AM J PATHOL, V145, P574
  • [12] Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
    Mori, K
    Duh, E
    Gehlbach, P
    Ando, A
    Takahashi, K
    Pearlman, J
    Mori, K
    Yang, HS
    Zack, DJ
    Ettyreddy, D
    Brough, DE
    Wei, LL
    Campochiaro, PA
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (02) : 253 - 263
  • [13] Okamoto N, 1997, AM J PATHOL, V151, P281
  • [14] Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
    Ozaki, H
    Seo, MS
    Ozaki, K
    Yamada, H
    Yamada, E
    Okamoto, N
    Hofmann, F
    Wood, JM
    Campochiaro, PA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) : 697 - 707
  • [15] Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates
    Ozaki, H
    Hayashi, H
    Vinores, SA
    Moromizato, Y
    Campochiaro, PA
    Oshima, K
    [J]. EXPERIMENTAL EYE RESEARCH, 1997, 64 (04) : 505 - 517
  • [16] PEER J, 1995, LAB INVEST, V72, P638
  • [17] VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR EXPRESSION IN A MOUSE MODEL OF RETINAL NEOVASCULARIZATION
    PIERCE, EA
    AVERY, RL
    FOLEY, ED
    AIELLO, LP
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) : 905 - 909
  • [18] VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A POTENTIAL TUMOR ANGIOGENESIS FACTOR IN HUMAN GLIOMAS INVIVO
    PLATE, KH
    BREIER, G
    WEICH, HA
    RISAU, W
    [J]. NATURE, 1992, 359 (6398) : 845 - 848
  • [19] Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
    Robinson, GS
    Pierce, EA
    Rook, SL
    Foley, E
    Webb, R
    Smith, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) : 4851 - 4856
  • [20] Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
    Seo, MS
    Kwak, N
    Ozaki, H
    Yamada, H
    Okamoto, N
    Yamada, E
    Fabbro, D
    Hofmann, F
    Wood, JM
    Campochiaro, PA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) : 1743 - 1753